MARKET

PLSE

PLSE

Pulse Biosciences Inc
NASDAQ
15.96
-0.46
-2.80%
Closed 16:00 07/19 EDT
OPEN
16.57
PREV CLOSE
16.42
HIGH
17.08
LOW
15.86
VOLUME
179.52K
TURNOVER
0
52 WEEK HIGH
20.44
52 WEEK LOW
3.780
MARKET CAP
977.20M
P/E (TTM)
-19.5804
1D
5D
1M
3M
1Y
5Y
1D
Small-Cap Stocks 2024 Second Half Outlook - Buy Small Caps
Seeking Alpha · 5d ago
PULSE BIOSCIENCES INC - ENTERED INTO EQUITY DISTRIBUTION AGREEMENT RELATING TO OFFER AND SALE OF SHARES OF COMMON STOCK
Reuters · 6d ago
PULSE BIOSCIENCES INC -MAY OFFER AND SELL SHARES OF OUR COMMON STOCK AGGREGATE OFFERING PRICE OF UP TO $60 MLN FROM TIME TO TIME THROUGH AGENTS
Reuters · 6d ago
Weekly Report: what happened at PLSE last week (0708-0712)?
Weekly Report · 6d ago
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
The Russell 2000 index of small caps recorded its best weekly performance since October 2023. The index surged over 6% and reached its highest level since January 2022. The Russell 2000 posted a 3.6% daily gain after lower-than-expected June inflation data fueled speculation of potential interest rate cuts.
Benzinga · 07/12 20:25
Sector Update: Health Care Stocks Softer Late Afternoon
NASDAQ · 07/08 19:57
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Nikola, Cruise stocks
Chip stocks boosted the Nasdaq on Monday. The S&P 500 and the Dow edged lower as investors awaited a key inflation reading. The Dow Jones Industrial Average was down 0.09% at 39,342.14. The top three Nasdaq percentage gainers were semiconductors.
Reuters · 07/08 18:16
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Arhaus, Inc. (NASDAQ:ARHS) fell 7.9% to $14.55 on Monday. Morphic Holding, Inc (MORF) shares jumped 75% after Eli Lilly agreed to buy the company for $57 per share in cash. Zapp Electric Vehicles Group Limited shares jumped 71% after jumping around 50% on Friday. Paramount Corporation shares rose 3.8% in a $28 billion merger deal with Intel Corporation.
Benzinga · 07/08 17:16
More
About PLSE
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.

Webull offers Pulse Biosciences Inc stock information, including NASDAQ: PLSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLSE stock methods without spending real money on the virtual paper trading platform.